Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0WD8Z
|
|||
Drug Name |
Piperazine derivative 8
|
|||
Synonyms |
PMID28447479-Compound-25
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
BIOGEN MA INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H44N2O3
|
|||
Canonical SMILES |
CCCCCCCCOC1=CC=C(C=C1)N2CCN(CC2)CC34CCC(CC3)(CC4)C(=O)O
|
|||
InChI |
1S/C28H44N2O3/c1-2-3-4-5-6-7-22-33-25-10-8-24(9-11-25)30-20-18-29(19-21-30)23-27-12-15-28(16-13-27,17-14-27)26(31)32/h8-11H,2-7,12-23H2,1H3,(H,31,32)
|
|||
InChIKey |
BBLBOXJIVAKNRT-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | . | [1] |
Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
KEGG Pathway | Ether lipid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.